Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the ...
Hogan Lovells, Paul Weiss and Ireland's Arthur Cox and A&L Goodbody also act in tie-up of drugmakers with shared history of ...
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that the U.S. Food and Drug ...
Among these was a product called VIP Go Rhino Gold 69K from a sex shop in Quebec City, Quebec; Alien 2 Power Platinum 11000 ...
3d
The National on MSNChanging the fertility conversation: UAE experts on what to know about reproductive healthHow do we talk about the rise of infertility without creating anxiety? When is it appropriate to broach topics such as egg ...
Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after ...
Transaction Brings Together Two Highly Complementary Businesses to Broaden Patient Access and Develop New Therapies to Address Unmet Patient Needs Combined Company Expected to Benefit from Immediate ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have ...
Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...
under which Verity Pharma has the rights to market its testosterone replacement therapy product in the United States and also in Canada, if approved. The views and opinions expressed herein are ...
1d
News Medical on MSNLGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions, semi-solids, and suppositoriesLGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results